Skip to content

Research on the precision diagnosis and treatment system of adult moyamoya disease based on artificial intelligence

Research on the precision Diagnosis and treatment System of adult moyamoya disease based on artificial intelligence

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036708
Enrollment
Unknown
Registered
2020-08-24
Start date
2021-01-01
Completion date
Unknown
Last updated
2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Moyamoya disease

Interventions

precise bypass group:precise bypass

Sponsors

Huashan Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Case group: patients with moyamoya disease aged 18-80 years old, male or female, right-handed, no evidence of cerebral stroke or surgical history in MRI structural phase; 2) All subjects fully understood the revised study and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1) The presence of other diseases and medication that may affect cognitive function; 2) Associated with other neurological and psychiatric diseases; 3) Have other serious systemic diseases; 4) Unable to independently complete cognitive test and image data collection; 5) Participate in other clinical trials at the same time; 6) Has undergone craniocerebral surgery.

Design outcomes

Primary

MeasureTime frame
post operative stroke events;Perioperative complication;

Countries

China

Contacts

Public ContactYuxiang Gu

Huashan Hospital, Fudan University

guyuxiang1972@126.com+86 13801847125

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026